Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9‐year study-Reference-Cited by-同舟云学术

Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9‐year study

Published:2015-10-05 Issue:4 Volume:1 Page:403-411
ISSN:2352-8729
Container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
language:en
Short-container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Author:

Stomrud Erik¹²,Minthon Lennart¹²,Zetterberg Henrik³⁴,Blennow Kaj³,Hansson Oskar¹²

Affiliation:

1. Clinical Memory Research Unit, Department of Clinical Sciences, MalmöLund University, Skåne University HospitalMalmöSweden

2. Memory ClinicSkåne University HospitalMalmöSweden

3. Clinical Neurochemistry LaboratoryDepartment of Psychiatry and NeurochemistryInstitute of Neuroscience and PhysiologySahlgrenska AcademyUniversity of GothenburgMölndalSweden

4. UCL Institute of NeurologyLondonUK

Funder

Vetenskapsrådet

Crafoordska Stiftelsen

Hjärnfonden

Swedish Brain Power

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.dadm.2015.09.002